Navigation Links
Lilly Announces Senior Leadership Changes
Date:2/11/2011

INDIANAPOLIS, Feb. 11, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that Sue Mahony, currently senior vice president of human resources and diversity, has been named senior vice president and president of Lilly Oncology.

In this new role she continues to report to John Lechleiter, Ph.D., Lilly chairman, president, and CEO, and she remains a member of the company's executive committee. Mahony succeeds John H. Johnson, who resigned last month.

Being promoted into Mahony's former role is Steve Fry, currently vice president of human resources for two of Lilly's business areas, bio-medicines and emerging markets. Fry now joins Lilly's executive leadership team and reports to Lechleiter. Both moves are effective immediately.

Mahony

"Sue brings a deep understanding of both the scientific and commercial aspects of our business gained through a broad range of leadership roles here at Lilly and with other major pharmaceutical companies," said Lechleiter. "Lilly has one of the largest clinical-stage pipelines of potential cancer medicines in the industry. Sue is a proven leader who will help Lilly make the most of these incredible opportunities."

Mahony joined Lilly more than 10 years ago after a decade in sales and marketing roles in the United Kingdom and Europe in oncology/hematology and cardiovascular medicine for Amgen, Bristol-Myers Squibb, and Schering-Plough. She was named general manager of Lilly Canada in 2008 after roles in global marketing and new product development, including a leadership role in the development of Cymbalta®. Mahony was also the Six Sigma leader for Lilly's sales and marketing component. She was promoted to the top human resources role in 2009.

Mahony received her bachelor's degree and Ph.D. in pharmacy, in the Cancer Research Campaign Experimental Chemotherapy Group, from Aston Uni
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
4. Lilly Receives NCQA Design Certification for Depression Care Management Program
5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... , September 18, 2014 ... audience, has updated the incredibly successful Serialisation Countdown calendar ... interactive PDF, available at pharmaserialisation.com shows the ... which they will be coming into force. ... longer a matter of "if", but "when" they will ...
(Date:9/18/2014)... 2014  A $3 million grant from The Glenn ... Michigan to establish a national center of excellence in ... Aging Research at U-M will focus on exploiting and ... effects of aging and postpone diseases in animal models. ... help develop medications that may help people live longer, ...
(Date:9/18/2014)... PLAINSBORO, N.J. , Sept. 18, 2014 ... the National Hemophilia Foundation,s (NHF) new three-year initiative, ... to people with hemophilia and their families/caregivers to ... can impede disease management. The curriculum for the ... Your Provider About Pain , focuses on improving ...
Breaking Medicine Technology:Pharma IQ Displays Worldwide Serialisation Deadlines in their 2014 - 2018 Countdown Calendar 2$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 2$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 3Novo Nordisk Supports National Hemophilia Foundation Initiative for "Collaborating in Care" Disease Management Program 2Novo Nordisk Supports National Hemophilia Foundation Initiative for "Collaborating in Care" Disease Management Program 3
... TARRYTOWN, N.Y., Nov. 2, 2011 Siemens Healthcare Diagnostics ... a partnership aimed at setting new standards in ... of patients, infectious disease states and potential treatment paths. ... make existing Siemens molecular HIV tests compatible with the recently ...
... world leader in diabetes care, announced today that it has ... (DHF), a non-profit organization that raises diabetes awareness and connects ... of the Drive the Switch program, which has motivated more ... and their doctor about options for insulin delivery, like the ...
Cached Medicine Technology:New Siemens - Illumina Partnership Targets Clinical Infectious Disease Testing Using Next-Generation Sequencing 2New Siemens - Illumina Partnership Targets Clinical Infectious Disease Testing Using Next-Generation Sequencing 3Novo Nordisk Donates $50,000 to Diabetes Hands Foundation in Recognition of the Drive the Switch Program's Inaugural Year 2Novo Nordisk Donates $50,000 to Diabetes Hands Foundation in Recognition of the Drive the Switch Program's Inaugural Year 3Novo Nordisk Donates $50,000 to Diabetes Hands Foundation in Recognition of the Drive the Switch Program's Inaugural Year 4Novo Nordisk Donates $50,000 to Diabetes Hands Foundation in Recognition of the Drive the Switch Program's Inaugural Year 5Novo Nordisk Donates $50,000 to Diabetes Hands Foundation in Recognition of the Drive the Switch Program's Inaugural Year 6Novo Nordisk Donates $50,000 to Diabetes Hands Foundation in Recognition of the Drive the Switch Program's Inaugural Year 7
(Date:9/18/2014)... ORLANDO, Fla., and DENVER (PRWEB) September 18, 2014 ... office in Orlando. This new office, managed by Todd ... provide health systems in the southeast with the benefits ... without sacrificing the knowledge and advantage of local project ... regional offices, NexCore has expanded its presence across the ...
(Date:9/18/2014)... September 18, 2014 Once again, Hickman’s ... breakfast restaurants around the Valley to celebrate PJs & ... “World Egg Day”: Friday, October 10, 2014. The “breakfast ... locations to benefit Arizona’s Children Association (AzCA) foster care ... dinner at each participating restaurant on October 10 are ...
(Date:9/18/2014)... are trying to learn more about a condition called ... young athletes. In people with sickle cell trait, ... breakdown that can lead to kidney damage and cardiac ... in the United States collapsed and died during training ... "More student-athletes with sickle cell trait have died ...
(Date:9/18/2014)... decades, researchers have tried to develop broadly effective vaccines ... malaria, and tuberculosis. While limited progress has been made ... available that can protect most people from these devastating ... when vaccines just aren,t working? , At Caltech, Nobel ... problem in a different way. Whereas vaccines introduce substances ...
(Date:9/18/2014)... to support private efforts to provide mental health services ... for similar efforts should federal officials decide to expand ... the VA health system, according to a new RAND ... joint project of philanthropic groups and major academic medical ... and other services to veterans and their families. , ...
Breaking Medicine News(10 mins):Health News:NexCore Group Opens Regional Office in Orlando, Florida 2Health News:October 10th Is 6th Annual PJs & Eggs: Hickman’s Family Farms and Breakfast Restaurants Partner to Benefit Arizona Foster Children 2Health News:Scientists Studying Sickle Cell Trait 2Health News:A new way to prevent the spread of devastating diseases 2Health News:A new way to prevent the spread of devastating diseases 3Health News:A new way to prevent the spread of devastating diseases 4Health News:A new way to prevent the spread of devastating diseases 5Health News:Study provides insight about providing private mental health service to veterans 2Health News:Study provides insight about providing private mental health service to veterans 3
... the U.S., demonstrated both the efficacy and ... with nasal symptoms associated with perennial allergic ... today the U.S. Food and Drug Administration (FDA) ... children aged 2-5,years old for the treatment of ...
... unclear, experts say , , MONDAY, Sept. 22 (HealthDay News) ... to take much longer to get to the hospital when ... new study finds. , The finding suggests that patients without ... critical window for time-sensitive care following a heart attack, the ...
... Cyberonics, Inc. (Nasdaq:,CYBX) today announced that its corporate ... The facility incurred no damage from the ... resulting in the Company operating from its,disaster recovery ... returned to normal, including all shipments and production ...
... experience trouble, study finds , , MONDAY, Sept. 22 (HealthDay ... -- which include Crestor, Lipitor, Pravachol and Zocor -- ... Canadian study indicates. , Delirium is a common, and ... of surgery, according to study lead author Dr. Donald ...
... previously unknown mechanism of immunity suggests that there may ... adults against Streptococcus pneumoniae (pneumococcal) infection, say researchers at ... (HSPH). The findings, published in the open-access journal ... development of novel pneumococcal vaccines. (The current vaccine, Prevnar, ...
... Pa., Sept. 22 A group of southeastern,Pennsylvania ... on,Thursday, September 25 at 12:00 PM at their ... maternity care crisis in Pennsylvania, and how a,legislative ... State,Representative Mike Vereb (R-Montgomery) and other legislators from,southeastern ...
Cached Medicine News:Health News:FDA Approves Nasacort AQ(R) Nasal Spray for Children Aged 2-5 years old 2Health News:FDA Approves Nasacort AQ(R) Nasal Spray for Children Aged 2-5 years old 3Health News:FDA Approves Nasacort AQ(R) Nasal Spray for Children Aged 2-5 years old 4Health News:Heart Attack Care Often Delayed for the Poor 2Health News:Heart Attack Care Often Delayed for the Poor 3Health News:Cyberonics Corporate Headquarters Fully Operational Following Hurricane Ike 2Health News:Cyberonics Corporate Headquarters Fully Operational Following Hurricane Ike 3Health News:Cholesterol Drugs May Raise Post-Op Delirium Risk 2Health News:Cholesterol Drugs May Raise Post-Op Delirium Risk 3Health News:New insights could lead to a better pneumococcal vaccine 2
Fundamental help with all major urologic conditions and diseases, plus time-saving recommendations on important problems....
This easy-to-navigate reference provides clear, current, clinically proven recommendations for diagnosis and treatment of neurologic disorders....
... Cochrane Reviews enable all those involved ... date with the very latest evidence in ... which becomes harder each year as the ... this problem by delivering the best single ...
... eText is a concise yet complete ... recommendations for cardiovascular disease. In addition ... electronic textbook, a full desktop version ... In addition to the electronic textbook, ...
Medicine Products: